ADIM
ANF icon

Alpha DNA Investment Management’s Abercrombie & Fitch ANF Stock Holding History

Alpha DNA Investment Management’s Portfolio ANF Stock Details ANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,857
Closed -$577K – 22
2024
Q4 		$577K Buy
3,857
+253
+7% +$37K 0.22% 95
2024
Q3 		$504K Buy
3,604
+1,306
+57% +$199K 0.19% 111
2024
Q2 		$409K Buy
+2,298
New +$333K 0.16% 159
2023
Q2 		– Sell
-41,566
Closed -$1.15M – 155
2023
Q1 		$1.15M Buy
+41,566
New +$1.16M 0.34% 70
2021
Q3 		– Sell
-29,410
Closed -$1.36M – 105
2021
Q2 		$1.36M Buy
29,410
+29,293
+25,037% +$1.18M 0.93% 77
2021
Q1 		$4K Buy
+117
New +$3.23K ﹤0.01% 394

Other funds holding ANF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alpha DNA Investment Management's ANF Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Abercrombie & Fitch (ANF) in Q1 2025, closing a stake of 3,857 shares — an estimated $577K sold.

Alpha DNA Investment Management first reported a position in ANF in Q1 2021 and held it in 6 quarters. The position peaked at $1.36M in Q2 2021. 403 funds tracked by Wall St. Rank hold ANF as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Abercrombie & Fitch position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,857 Abercrombie & Fitch shares in Q1 2025, an estimated $577K.
  • Alpha DNA Investment Management first reported a position in Abercrombie & Fitch in Q1 2021 and held it in 6 quarters.
  • Alpha DNA Investment Management's Abercrombie & Fitch position peaked at $1.36M in Q2 2021.
  • 403 funds tracked by Wall St. Rank held Abercrombie & Fitch as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.